Evidence map›Paper›PMID 38829879›Full record

ArticlePloS one2024

Benzathine penicillin G stockouts and other barriers to documented syphilis treatment in pregnancy in Zambia.

Anna V Jones, Albert Manasyan, Yumo Xue, Herbert Kapesa, Kate Mwendafilumba, Leukanji Nalwamba, Maureen Mzumara, Mwangelwa Mubiana-Mbewe, Jodie A Dionne

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Low syphilis treatment rates and associated birth outcomes in pregnant women with and without HIV in Zambia: A cohort study.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anna V JonesHeersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.ORCID 0000-0002-7685-4489
Albert ManasyanDepartment of Pediatrics, University of Alabama at Birmingham, Children's of Alabama Hospital, Birmingham, Alabama, United States of America.ORCID 0000-0001-6275-245X
Yumo XueHeersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Herbert KapesaCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Kate MwendafilumbaCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Leukanji NalwambaCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Maureen MzumaraCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Mwangelwa Mubiana-MbeweCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Jodie A DionneCenter for Women's Reproductive Health, University of Alabama at Birmingham, University of Alabama at Birmingham Hospital, Birmingham, Alabama, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe prevalence of syphilis in Zambia remains high and is a critical public health concern. The Zambian Ministry of Health recommends universal screening and same-day treatment for syphilis in pregnancy, yet the syphilis screening rate is low, and treatment is poorly documented. The goal of this study was to document syphilis treatment rates and associated factors among pregnant women in care in Zambia.

methodsThis retrospective cohort study included pregnant women diagnosed with syphilis according to rapid plasma reagin (RPR) screening during routine antenatal care (ANC) in Lusaka, Zambia in 2018-2019. The main outcome of interest was lack of documented BPG treatment during pregnancy. Additional information about pregnancy and neonatal outcomes, partner referral for therapy, and facility level stockout data were included. Patient characteristics were compared by treatment status using Pearson Chi-Square Test and logistic regression models were created to estimate the association between individual level-factors, facility type, and lack of BPG treatment. A Cochran-Mantel-Haenszel test was used to evaluate facility-level data with significance set at p<0.05.

resultsAmong 1,231 pregnant women who screened positive for syphilis at clinic, 643 (52%) lacked documented antibiotic treatment at the facility. BPG was the only antibiotic used to treat syphilis in the cohort and 8% of sex partners had evidence of referral for therapy. Preterm delivery rates were higher in women without documented BPG (43% vs 32%; p = 0.003). In adjusted models, only calendar year and hospital facility type were associated with lack of treatment. At the facility level, annual syphilis screening rates ranged from 37-65% and most (7/10) clinics reported at least one stockout of BPG.

conclusionTreatment rates for syphilis in pregnancy in Zambia were low and BPG medication stockouts at the facility level were common. A consistent supply of BPG at all ANC facilities is needed to facilitate timely treatment and improve birth outcomes.

Indexed as

Penicillin G BenzathinePregnancy Complications, InfectiousPrenatal CareSyphilisAdolescentAdultAnti-Bacterial AgentsFemaleHumansPregnancyRetrospective StudiesYoung AdultZambiaAnti-Bacterial AgentsPenicillin G Benzathine

Identifiers

PMID38829879
PMCPMC11146727

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.